Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

First Trust NYSE Arca Biotechnology Index Fund (FBT)

Delayed Data
As of 6:30pm ET
 +0.68 / +0.54%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. It is non-diversified.

No recent news for First Trust NYSE Arca Biotechnology Index Fund.


1 month+2.26% 3 years+12.53%
3 months+9.23% 5 years+22.42%
1 year+40.60% Since inception+17.79%
Data through 10/17/2017

Quote Details

Previous close$126.10
Open day’s range126.18 – 127.29
Net asset value (NAV)126.05 (10/16/2017)
Daily volume61,020
Average volume (3 months)54,612
Data as of 6:30pm ET, 10/17/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+22.42%+16.79%
Expense Gross exp ratio0.56%1.33%
Risk 5 year sharpe ratio0.941.10
Net assets$1.2B$3.1B
Average market cap$11.8B$30.9B
Average P/E--26.2
Dividend / Share--0.28%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
-- 5.28%
JUNO Juno Therapeutics Inc4.80%
ALNY Alnylam Pharmaceuticals Inc4.63%
NBIX Neurocrine Biosciences Inc4.05%
ACAD ACADIA Pharmaceuticals Inc4.05%
ILMN Illumina Inc3.69%
AGIO Agios Pharmaceuticals Inc3.65%
GILD Gilead Sciences3.52%
BIIB Biogen3.52%
NKTR Nektar Therapeutics3.42%